Crossmark

Construction and Expression of Fc-FGF21 by Different Expression Systems and Comparison of Their Similarity and Difference with Efruxifermin by In Vitro and In Vivo Studies

Crossref DOI link: https://doi.org/10.1007/s12010-024-05107-x

Published Online: 2024-12-19

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xujia

Meng, Qin

Jia, Aijuan

Zhou, Yuehua

Song, Dandan

Ma, Shaokang

Li, Wei

Zhang, Zhuobing

Goldring, Christopher

Feng, Hui

Wang, Mu https://orcid.org/0009-0007-3584-6873
License Information

Text and Data Mining valid from 2024-12-19

Version of Record valid from 2024-12-19
More Information

Article History

Accepted: 19 November 2024

First Online: 19 December 2024

Declarations

:

: Animal study protocols (ASP) were approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai Junshi Biosciences Co., Ltd. (Shanghai, China), and all in vivo experiments were conducted according to IACUC guidelines.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below